Longitudinal Racial/Ethnic Disparities in Antimanic Medication Use in Bipolar-I Disorder

OBJECTIVE: To examine racial/ethnic longitudinal disparities in antimanic medication use among adults with bipolar-I disorder. METHODS: Observational study using administrative data from Florida's Medicaid program, July 1997 to June 2005, for enrollees diagnosed with bipolar-I disorder (N = 13,497 persons; 126,413 person-quarters). We examined the likelihood of receiving one of the following during a given quarter: (1) any antimanic agent (antipsychotic or mood stabilizer) or none, and (2) mood stabilizers, antipsychotic monotherapy, or neither. Binary and multinomial logistic regression models predicted the association between race/ethnicity and prescription fills, adjusting for clinical and demographic characteristics. Cohort indicators for year that the enrollee met study criteria were included to account for cohort effects. RESULTS: Averaging over all cohorts and quarters, compared with whites, blacks had lower odds of filling any antimanic and mood stabilizer prescriptions specifically (40%-49% and 47%-63%, respectively), but similar odds of filling prescriptions for antipsychotic monotherapy. After Bonferroni adjustment, compared with whites, there were no statistically significant disparities for Hispanics in filling prescriptions for any, or specific antimanic medications. CONCLUSIONS: Rates of antimanic medication use were low regardless of race/ethnicity. However, we found disparities in antimanic medication use for blacks compared with whites and these disparities persisted over time. We found no Hispanic-white disparities. Quality improvement efforts should focus on all individuals with bipolar disorder, but particular attention should be paid to understanding disparities in medication use for blacks

Antipsychotic · Bipolar disorder · Cohort · Ethnic group · Health care · Logistic regression · Medicaid · Medical prescription · Mood · Mood stabilizer · Psychiatry · Schizophrenia (object-oriented programming) · Bipolar Disorder and Treatment · Demography · Electroconvulsive Therapy Studies · Internal Medicine · Medicine · Pharmacology · Psychology · Schizophrenia research and treatment

• The Rise and Fall of Gabapentin for Bipolar Disorder

  Catherine A Fullerton, Alisa B Busch et al.•Medical Care•2010

  Incluir item

• The Effects of the Transition From Medicaid to Medicare on Health Care Use for Adults With Mental Illness

  Margaret E Burns, Marguerite E Burns et al.•Medical Care•2016

  Incluir item

• Disparities in Treatment and Service Utilization Among Hispanics and Non-Hispanic Whites with Bipolar Disorder

  Open Access•Stephanie Salcedo, Kaja J Mcmaster et al.•Journal of Racial and Ethnic…•2017

  Incluir item

• Longitudinal Data Analysis for Discrete and Continuous Outcomes

  Scott L Zeger, Kung-Yee Liang et al.•Biometrics•1986

  Incluir item

• Race, Ethnicity, and the Use of Services for Mental Disorders

  Harold W Neighbors, Cleopatra H Caldwell et al.•Archives of General Psychiatry•2007

  Incluir item

• New Evidence Regarding Racial And Ethnic Disparities In Mental Health

  Thomas G Mcguire, Jeanne Miranda•Health Affairs•2008

  Incluir item

• The Mental Health of Black Caribbean Immigrants

  David R Williams, Rahwa Haile et al.•American Journal of Public Health•2007

  Incluir item

• Correlates of Past-Year Mental Health Service Use Among Latinos

  Margarita Alegria, Norah Mulvaney-Day et al.•American Journal of Public Health•2007

  Incluir item

• The Acceptability of Treatment for Depression Among African-American, Hispanic, and White Primary Care Patients

  Lisa A Cooper, Junius J Gonzales et al.•Medical Care•2003

  Incluir item

• Mental Health Service Utilization by African Americans and Whites

  Lisa Cooper-Patrick, Joseph J Gallo et al.•Medical Care•1999

  Incluir item